Related Experiment Video
Updated: Aug 13, 2026
09:19
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
Tumor sensitizing effect by misonidazole in a clinically relevant radiation dose range
Summary
Misonidazole sensitizes hypoxic fibrosarcoma cells to radiation, enhancing treatment efficacy. It also directly kills hypoxic cells, showing promise for cancer therapy.
Area of Science:
- Radiation oncology
- Cancer biology
- Pharmacology
Background:
- Hypoxic tumor cells are resistant to radiation therapy.
- Misonidazole is a potential radiosensitizer and cytotoxic agent for hypoxic cells.
Purpose of the Study:
- To evaluate the efficacy of misonidazole in sensitizing murine fibrosarcoma cells (oxic and hypoxic) to radiation.
- To determine the direct cytotoxic effect of misonidazole on hypoxic tumor cells.
Main Methods:
- Murine fibrosarcoma cells (oxic and hypoxic subpopulations) were isolated using density gradients.
- Cells were exposed to radiation alone or in combination with misonidazole.
- Cell survival was assessed using a lung colony assay.
Main Results:
- Misonidazole significantly enhanced radiation's effect on hypoxic cells (SER of 1.9) but had a smaller effect on oxic cells (SER of 1.3).
- Misonidazole alone demonstrated direct cytotoxicity against hypoxic cells, reducing their population by 50%.
- Oxic cells were unaffected by misonidazole's cytotoxic action.
Conclusions:
- Misonidazole effectively sensitizes hypoxic tumor cells to radiation within a clinical dose range.
- Misonidazole exhibits direct cytotoxic activity against hypoxic tumor cells, suggesting a dual therapeutic mechanism.
